Medtronic (MDT) is back in focus after William Blair upgraded the stock to Outperform, highlighting new product ramps tied to ...

Medtronic disclosed Diabetes unit executive pay packages for 2025 and compensation targets for when they'll lead MiniMed as a ...

Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft ...

Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...

The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.

These technologies are improving all the time. If they’re not making claims that they are medical grade, let’s let the market ...

Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with type 2 diabetes and your fit-fluencer friend. Jake Leach, who took over as Dexcom CEO today, wants ...

Spinal cord stimulators can significantly improve patients’ lives. The province doesn’t fund nearly enough of them, experts ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

However, it's also important not to forget about proven strategies for earning excellent returns over the long run, including investing in top dividend stocks. Below, I'll consider two that look like ...

Johnson & Johnson MedTech (NYSE: JNJ) announced today that it submitted its Ottava surgical robotic system to the FDA for de ...

The U.S. FDA will limit its regulation of health and fitness wearables, clarifying that low-risk wellness devices, such as ...